abstract |
The present invention provides a kind of compounds indicated by general formula I, its pharmaceutical salt, enantiomter, diastereoisomer or racemic modification, preparation method, comprising its pharmaceutical composition and its in preparation for treat by the purposes in the drug of EED and/or the PRC2 disease mediated or illness.Compound of the present invention can be used for treating the disease or illness mediated by PRC2. |